MAM
Eris Lifesciences appoints Boman Irani as Circa’s brand ambassador
MUMBAI: Eris Lifesciences has announced an association with the well-known theatre and film actor, Boman Irani, for their Circa range of devices. The association is aimed at highlighting the importance of an accurate and validated BP monitoring device.
The focus of the campaign is to encourage hypertensive patients to measure their blood pressure at home using a validated device while making an appeal to share their readings with the doctor. The campaign theme #ShareYourPressure urges users to stop worrying about getting a false reading and trust the device to share their pressure.
Boman Irani said, “It gives me immense pleasure to start this journey with Circa. For blood pressure management, the latest norms require a person to monitor it at least 2 times a day in the morning and evening. With technology advancing manifolds, it is only important for us to bring the same into our healthcare systems and adopt validated devices that can provide timely updates when required.”
The campaign will go live on social media channels this week in the form of short videos.
Eris Lifesciences Chairman and MD Amit Bakshi said, “Hypertension therapy is our second largest therapy and with cardiovascular being the No. 1 Chronic therapy, we are upping our ante by closing the loop with one of the most validated devices for blood pressure management. We have world-class data in the form of ‘India Heart Study’ conducted on the same ‘Circa’ device further validating our commitment to Hypertension therapy.
"With Boman Irani on board, we feel this partnership with the brand will increase awareness around Home Blood pressure monitoring (HBPM) and bring more people to target Blood pressure.”
The coronavirus outbreak has highlighted that patients with co-morbidities, E.g. Hypertension, are vulnerable to developing serious complications. Hence, an accurate measurement of blood pressure at home becomes extremely crucial. Any error in the measurement of blood pressure because of non-validated devices can put the life of the patient at risk.
MAM
Dish TV shareholders approve three independent directors
99.49 per cent vote of confidence strengthens board as company expands into connected TV, e-commerce and OTT.
MUMBAI: Dish TV has just been served a near-perfect vote of confidence and the shareholders have dished it out in style. Shareholders of the DTH operator have approved the appointment of three new Independent Directors with an overwhelming 99.49 per cent approval. The three appointees are Mr Arun Kumar Kapoor, Ms Heena Naishadh Bhatt and Mr Ashok Anant Paranjpe.
The strong mandate reflects continued investor faith in the company’s strategy, disciplined execution and long-term value creation. It comes as Dish TV focuses on stabilising its core DTH business while actively scaling new verticals connected TV platform VZY, B2B e-commerce ShopZop, and OTT service Watcho to build a more diversified and resilient growth trajectory.
Dish TV India Limited, CEO & executive director Manoj Dhobhal said, “We are encouraged by the shareholders’ approval of the appointment of the Independent Directors and sincerely thank them for their continued trust and confidence. The Board is already benefiting from the Directors’ collective experience, which will further sharpen strategic focus and support disciplined execution.”
With a fresh, strengthened board in place, Dish TV is well positioned to navigate the evolving media landscape. In a sector where every percentage point matters, a 99.49 per cent thumbs-up is the kind of ringing endorsement that suggests the company’s recipe for the future is already tasting right.
